New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

In many recurrent and/or metastatic cancers, the advent of immunotherapy opens up new scenarios of treatment response, with new phenomena, such as pseudoprogression and hyperprogression. Because of this, different immune-related response criteria have been developed, and new therapeutic strategies a...

詳細記述

書誌詳細

主要な著者:	Andrea Alberti, Luigi Lorini, Marco Ravanelli, Francesco Perri, Marie Vinches, Paolo Rondi, Chiara Romani, Paolo Bossi
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2022-06-01
シリーズ:	Vaccines
主題:	immunotherapy response criteria recurrent and/or metastatic head and neck squamous cell carcinoma pseudoprogression hyperprogression
オンライン･アクセス:	https://www.mdpi.com/2076-393X/10/6/885
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!